Amidst a backdrop of fluctuating bond markets and persistent inflation concerns, the Asian market has shown resilience, with growth stocks continuing to attract investor interest. In this environment, companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name | Insider Ownership | Earnings Growth |
| Suzhou Dongshan Precision Manufacturing (SZSE:002384) | 33.5% | 74.9% |
| Shanghai Biren Technology (SEHK:6082) | 10.4% | 119.7% |
| Meitu (SEHK:1357) | 23% | 26.9% |
| L&C BIOLTD (KOSDAQ:A290650) | 20.9% | 163% |
| KCTech (KOSE:A281820) | 20.6% | 31.6% |
| Jiangxi Fushine Pharmaceutical (SZSE:300497) | 21.1% | 50.8% |
| JHT DesignLtd (SHSE:603061) | 23.1% | 48.6% |
| Great Microwave Technology (SHSE:688270) | 21.1% | 95.2% |
| Gpixel Changchun Microelectronics (SEHK:3277) | 18.2% | 31.9% |
| Fulin Precision (SZSE:300432) | 11.2% | 66.5% |
Underneath we present a selection of stocks filtered out by our screen.
Exicon (KOSDAQ:A092870)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Exicon Co., Ltd. is a semiconductor test solution company operating in Korea and internationally, with a market cap of ₩608.69 billion.
Operations: Exicon generates revenue through its semiconductor test solutions business, serving both domestic and international markets.
Insider Ownership: 17.3%
Earnings Growth Forecast: 33.9% p.a.
Exicon is poised for significant growth, with earnings expected to increase by 33.9% annually and revenue projected to grow at 40.5% per year, outpacing the KR market. Despite its high volatility in recent months, Exicon's shares are trading at a substantial discount of 58.9% below estimated fair value. The company has recently turned profitable but lacks recent insider trading data, which could be a consideration for potential investors seeking transparency in insider activities.
- Click here to discover the nuances of Exicon with our detailed analytical future growth report.
- Insights from our recent valuation report point to the potential undervaluation of Exicon shares in the market.
SEERS (KOSDAQ:A458870)
Simply Wall St Growth Rating: ★★★★★★
Overview: SEERS Co., Ltd. develops, manufactures, and sells medical devices in South Korea with a market cap of ₩1.06 billion.
Operations: SEERS Co., Ltd. focuses on the development, manufacturing, and sales of medical devices in South Korea.
Insider Ownership: 33.8%
Earnings Growth Forecast: 37.8% p.a.
SEERS is set for impressive growth, with revenue expected to increase by 38.2% annually, surpassing the KR market's pace. The company's earnings are forecasted to rise significantly at 37.8% per year, while its Return on Equity is projected to be very high in three years. Despite recent share price volatility, SEERS trades at a considerable discount of 67.2% below fair value and has no substantial insider trading information available over the past three months.
- Dive into the specifics of SEERS here with our thorough growth forecast report.
- Our expertly prepared valuation report SEERS implies its share price may be too high.
Espressif Systems (Shanghai) (SHSE:688018)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Espressif Systems (Shanghai) Co., Ltd. is a fabless semiconductor company that develops and sells advanced low-power wireless communication chipsets globally, with a market cap of CN¥26.88 billion.
Operations: The company generates revenue primarily from its semiconductor segment, amounting to CN¥2.80 billion.
Insider Ownership: 37%
Earnings Growth Forecast: 22.8% p.a.
Espressif Systems (Shanghai) is poised for robust growth, with revenue expected to rise 23.5% annually, outpacing the Chinese market. Earnings are forecasted to grow significantly at 22.78% per year, though slower than the market average of 27.7%. Despite recent share price volatility and a relatively low Return on Equity forecast of 15.4%, Espressif's valuation appears attractive with a P/E ratio of 47.1x below industry norms, supported by strategic share buybacks totaling CNY 200 million recently completed for employee incentives.
- Get an in-depth perspective on Espressif Systems (Shanghai)'s performance by reading our analyst estimates report here.
- Our valuation report here indicates Espressif Systems (Shanghai) may be overvalued.
Next Steps
- Gain an insight into the universe of 488 Fast Growing Asian Companies With High Insider Ownership by clicking here.
- Contemplating Other Strategies? We've found 6 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com